[ Price : $8.95]
FDA commissioner Robert Califf tells a podcast that drug manufacturers have fought FDA efforts to encourage companies to produce m...[ Price : $8.95]
FDA medical reviewers tell the Endocrinologic and Metabolic Drugs Advisory Committee that they believe the Intarcia NDA for its IT...[ Price : $8.95]
Two attorneys say their review of drug preemption cases shows that the defense is demanding but can be attained.[ Price : $8.95]
FDA grants Disc Medicine a fast-track designation for MWTX-003 and its use for treating patients with polycythemia vera.[ Price : $8.95]
Relmada Therapeutics says a Phase 3 trial in Major Depressive Disorder shows that patients treated daily with REL-1017 for up to o...[ Price : $8.95]
Taysha Gene Therapies says it is discontinuing the development of its gene therapy TSHA-120 program as a treatment for giant axona...[ Price : $8.95]
UCB says its BLA for plaque psoriasis drug bimekizumab is facing another FDA review extension.[ Price : $8.95]
Federal Register notice: FDAs Office of Womens Health and Office of Clinical Pharmacology announces a 10/11 public workshop: Menop...